Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
News 9 Jun 2015 After more than a decade of effort and achievements, DNDi hands over malaria programme to MMV
News 26 May 2015 GHIT Fund invests $4 million into Takeda Pharmaceutical Company Limited and DNDi partnership to develop new visceral leishmaniasis drug
News 3 Mar 2015 DNDi congratulates team of researchers at University Hospital Bonn, which has received the Memento Research Award 2015 for their commitment against neglected diseases
News 10 Feb 2015 DNDi joins forces with leading organizations to tackle the deadly tropical disease, Visceral Leishmaniasis
